Navigation Links
Breast Cancer Treatment Reduced From Six Weeks To Five Days.

A new therapy to treat breast cancer reduces the radiation time from six weeks to five days. This is very useful for the patients as it is less convenient. Doctors// can point the radiation source at the tumor killing the cancer cells.

The study compares the usefulness of the new therapy over the conventional six-week treatment. They are also in the process of analyzing the suitable subjects for this therapy.

But the Canadians are working on a new therapy for breast cancer, which reduces the treatment time to just 24 hours.

This can be possible by implanting radiation seeds permanently in the patient’s breast thereby facilitating the destruction of cancer cells. This method helps the patient o continue with their normal routine.

This new method of treatment of breast cancer is called partial-breast radiation therapy.

But experts have their reservations and tell the patients who opt or the new therapy to enroll them in the study wherein they are testing the feasibility of the new approach.

But Dr. Norman Coleman working at the national cancer institute questions the researchers the effectiveness of the new therapy as this can work well in few patients and only very few patients are followed to ensure that this is therapy works better than the conventional one.

Dr. Frank Vicini of William Beaumont Hospital in Royal Oak, Mich., who initiated the five-day approach and is currently presiding the new NCI study.

He said that around 200,000 American (70%) suffering from breast cancer patients opt for a lumpectomy (removal of the tumor) and not the removal of the entire breast.

In addition to lumpectomy radiation helps in the treatment of early-stage breast cancer.

Partial-breast radiation is a very useful tehnique in the prevention of recurrence of breast cancer and also reduces the side effects faced during the conventional methods.


'"/>




Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: